Xeris Pharmaceuticals Inc reported $-18780000 in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acelrx Pharmaceuticals ACRX:US USD -6632000 2.04M
Eli Lilly And LLY:US USD 2.11B 169.2M
Endo International Ordinary Shares ENDP:US USD 55.64M 26.07M
Horizon Pharma HZNP:US USD 188.16M 41.16M
JAZZ PHA JAZZ:US USD 199.21M 72.86M
Nektar Therapeutics NKTR:US USD -37471000 10.24M
Pacira Pharmaceuticals PCRX:US USD 21.78M 8.6M
Perrigo Ordinary Shares PRGO:US USD 52.2M 49.6M
Teva Pharmaceutical Industries TEVA:US USD 740M 6M